Evaluation of the WATCHMAN Left Atrial Appendage (LAA) Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy

NCT01182441 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

407

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation
Stroke

Interventions

DEVICE: WATCHMAN Device
DRUG: Warfarin

Sponsor

Boston Scientific Corporation